| DR | degeneration reaction; delivery room; deoxyribose; diabetic retinopathy; diagnostic radiology; digit... |
|---|---|
| ERA | electrical response activity; electroencephalic response audiometry; Electroshock Research Associati... |
| ERP | early receptor potential; effective refractory period; elodoisin-related peptide; endoscopic retrogr... |
| GCGR | glucagon receptor; glucocorticoid receptor |
| INSRR | insulin receptor-related receptor |
| tension | 1. The act of stretching. 2. The condition of being stretched or strained, the degree to which anything is stretched or strained. 3. <physics> Voltage. 4. <chemistry> The partial pressure of a gas in a fluid, for example, of oxygen in blood. Origin: L. Tensio, Gr. Tonos (13 Jan 1998) |
|---|---|
| tension, arterial | The pressure of the blood within an artery, the arterial pressure. Also called the intra-arterial pressure. (12 Dec 1998) |
| tension curve | The direction of the trabeculae in cancellous bone tissue adapted to resist stress. (05 Mar 2000) |
| tension headache | <neurology> A benign form of headache that results from the painful spasm (muscle tightness) and inflammation of muscles of the head and neck. Tension headache is one of the most common forms of headache. Spasm and contraction of the head and neck muscles may occur in response to fatigue, overuse, eye strain, excessive smoking, stress, anxiety or depression. Sleeping in an abnormal position or prolonged work involving immobilisation of the neck in one position (typing, computers, etc.) are considered common triggers. Exercising and stretching the muscles of the head and neck can reduce the occurrence of muscle tension headaches. (13 Jan 1998) |
| tension, intraocular | The pressure within the eye. (12 Dec 1998) |
| tension, intravenous | The pressure of the blood within a vein, the venous pressure. (12 Dec 1998) |
| tension pneumothorax | A variety of spontaneous pneumothorax in which air enters the pleural cavity and is trapped during expiration; intrathoracic pressure builds to values higher than atmospheric pressure, compresses the lung, and may displace the mediastinum and its structures toward the opposite side, with consequent disadvantageous effects on blood flow. Synonym: pressure pneumothorax, valvular pneumothorax. (05 Mar 2000) |
| tension suture | <surgery> A heavy reinforcing suture placed deep within the muscles and fasciae of the abdominal wall to relieve tension on the primary suture line and thus obviate postoperative wound disruption. Synonym: tension suture. (05 Mar 2000) |
| tissue tension | A theoretical condition of equilibrium or balance between the tissues and cells whereby overaction of any part is restrained by the pull of the mass. (05 Mar 2000) |
| low tension glaucoma | Optic nerve atrophy and excavation with typical field defects of glaucoma but without abnormal increase in intraocular pressure. (05 Mar 2000) |
| acetylcholine receptor antibodies | <neurology, investigation> A test used to measure the amount of antibodies to acetylcholine receptors on nerve endings. This is a diagnostic test for myasthenia gravis. A normal value is no antibodies in the bloodstream. Acetylcholine receptor (AChR) binding autoantibodies (i.e. Antibodies reactive with several epitopes other than the binding site for acetylcholine or alpha-bungarotoxin) are present in approximately 88% of patients with generalised myasthenia gravis, 70% of ocular myasthenia and in approximately 80% of myasthenia gravis in remission. Although serum concentrations of AChR binding autoantibodies do not in general correlate well with severity of weakness, there is typical decrease in concentration as weakness improves with immunosuppressive therapy. AChR blocking autoantibodies (i.e., antibodies reactive with the AChR binding site) are present in about 50% of patients with myasthenia gravis, 30% with ocular myasthenia gravis and 20% of myasthenia gravis in remission, AChR blocking autoantibodies are the only AChR autoantibodies present in about 1% of myasthenia gravis. AChR modulating autoantibodies (i.e., autoantibodies which cross-link AChRs and cause their removal from muscle membrane surfaces) are present in more than 90% of myasthenia gravis and occasionally are the only AchR autoantibodies detectable in mild, recent onset or ocular-restricted myasthenia gravis. Results for AChR modulating autoantibodies can be transiently false-positive due to curare-like drugs used during general anesthesia. AChR autoantibodies of one or more types are found in at least 80% of ocular myasthenia gravis. Although generally absent in neurological conditions other than myasthenia gravis(and consequently unlikely to cause confusion in neurodiagnosis), false-positive results for AChR autoantibodies occasionally occur in primary biliary cirrhosis, tardive dyskinesia, autoimmune thyroiditis, the elderly, amyotrophic lateral sclerosis patients treated with cobra venom and patients with thymoma in the absence of myasthenia gravis. Approximately 1% of patients with rheumatoid arthritis treated with D-penicillamine develop AChR autoantibodies and myasthenia gravis, both of which disappear when the drug is discontinued. Babies born to ~10% of myasthenia gravis mothers have a transient neonatal form of myasthenia gravis that responds well to anticholinesterase therapy and usually remits within 1 month as maternal IgG disappears. (29 Dec 1997) |
| amino acid receptor | <biochemistry> Ligand gated ion channels with specific receptors for amino acid transmitters. An extended protein superfamily that also includes subunits of the nicotinic acetylcholine receptor. (18 Nov 1997) |
| AMPA receptor | <cell biology> Glutamate operated ion channel. See: excitatory amino acid receptor channels. (05 Feb 1998) |
| ANP receptor | <molecular biology> Family of 3 receptors for atrial natriuretic peptide. ANP A and ANP B have intracellular guanylate cyclase and protein kinase like domains. ANP C, shares the extracellular ligand binding and transmembrane domains, but lacks the functional intracellular domains and is not thought to be involved in signal transduction. (18 Nov 1997) |
| asialoglycoprotein receptor | A surface receptor found in hepatocytes that binds galactose-terminal glycoproteins; thus, this receptor removes those proteins from circulation and they are in turn acted upon by hepatocyte lysosomes. (05 Mar 2000) |